Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for addiction and other serious mental illnesses. Indivior manufactures and markets medicines for the treatment of moderate to severe opioid use disorder with a global portfolio in over 40 countries. Indivior also markets medicine for the treatment of schizophrenia in adults in the United States. Indivior strives to further the understanding of addiction and other serious mental health diseases.
- Terry Horton, MD, FACP, FASAM
Vice President, Patient Insights and Advocacy
- Nick Reuter
Director, Policy and Advocacy